DDB Remedy picks up Novartis OTC launch

Novartis, the pharmaceutical giant, has appointed DDB Remedy to handle the international roll-out of a new over-the-counter product.

Novartis: appoints DDB Remedy
Novartis: appoints DDB Remedy

The intermediary Hestbæk Consult handled the pitch, which began in November last year.

DDB Remedy, DDB’s health arm, will create a campaign for the product, dubbed "Project Cool", across Europe, the US and Asia. It is expected to target consumers and healthcare professionals.

The product is thought to relate to Novartis’ US high-strength pain-relief brand Excedrin. The tablet was recalled in the US last year after a series of faulty batches were distributed.

Novartis works with a number of agencies including DraftFCB London, Wunderman Switzerland and Grey Group.

Topics

Subscribe to Campaign from just £57 per quarter

Includes the weekly magazine and quarterly Campaign IQ, plus unrestricted online access.

SUBSCRIBE

Looking for a new job?

Get the latest creative jobs in advertising, media, marketing and digital delivered directly to your inbox each day.

Create an Alert Now
Brands that forge an emotional tie are best protected from copycats
Shares0
Share

1 Brands that forge an emotional tie are best protected from copycats

Forging an emotional tie with consumers is one of the strongest ways to protect your brand. Products can be copycatted, but the distinctive identity of a true brand can never be replicated argues Nir Wegrzyn, CEO of BrandOpus.

Just published